Tag: Biotechnology

BLUE chart uptrend channel on rising large players volume

Bluebird Bio Swing Long Setup

10/06/2018

Bluebird Bio looks like a pretty sweet swing long setup as the stock is testing uptrend channel support as large players volume surges higher. Bluebird Bio reported its quarterly earnings results on May 7, 2018. The company reported EPS of ($2.31) which missed the consensus estimate of ($2.01). Revenue crushed estimates, coming in at $15.96 Read More »

GILD chart shows nice setup with rising large players volume

Gilead Sciences Setup On Experimental Therapy Eliminating Woman’s Breast Cancer

4/06/2018

Gilead Sciences stock looks like a great setup on rumors circulating that Gilead has an experimental therapy that has completely eliminated breast cancer in women. I am unable to find the source of the rumors or verify its authenticity so caution is warranted. UPDATE: The source of the rumor is Bloomberg. Gilead Sciences’ experimental therapy Read More »

Amgen Coming Up On Adcom and PDUFA

28/02/2018

SUBSCRIBE OR SIGN IN

CDC Gives Thumbs Up For Insurance Companies To Include This Drug

21/02/2018

SUBSCRIBE OR SIGN IN

Exelixis Coming Up On Earnings Release February 26 2018

18/02/2018

Exelixis stock has a good consolidation setup going into its earnings release on February 26, 2018.

Gilead Sciences

Gilead Sciences Wins FDA Approval For Biktarvy

7/02/2018

Gilead Sciences looks like a good oversold, candle over candle setup.

Vertex stock

Vertex Pharmaceuticals PDUFA February 28 2018

6/02/2018

SUBSCRIBE OR SIGN IN

Ionis Pharmaceuticals stock

Is Ionis Pharmaceuticals Stock Ready To Explode Higher?

23/01/2018

The chart of Ionis Pharmaceuticals doesn’t look like much but the fundamentals show eye-popping revenue growth.

Synergy Pharmaceuticals Ahead of PDUFA

22/01/2018

Synergy Pharmaceuticals has a PDUFA ruling coming within the next couple of days. The Twiggs Money Flow has started to run ahead of the FDA announcement.

Amgen stock

Amgen Stock Setup On FDA Approval for Multiple Myeloma

9/01/2018

Amgen stock looks like a good setup as the Twiggs Money Flow breaks into positive territory.